News
  • About Us
  • Test serviecs
  • Regulations
  • R & D Service
  • News
  • Contact Us
  • Congratulations to Rainbowlabs for passing the CNAS inspecti

    2015-06-16 15:26:42
    Congratulations to Rainbowlabs for passing the CNAS inspecti
    A good news came that Rainbow Labs passed the site assessment of China National Accreditation Service for Conformity Assessment (CNAS) on November 9, 2014. At present, CNAS is the unique and most authoritative laboratory accreditation certification body. Being approved by CNAS, proves that our level and capacity are up to international standard, product inspection result reliable. The certificate or report issued by us, will be recognized by 56 countries in a mutual recognition system.

    Since then, Rainbow Labs becomes a laboratory which is approved and qualified by the US FDA, Health Canada and CNAS China at the same time. We will constantly make intensified effort on international registration and mutual recognition, unswervingly adhere to the strategy of quality innovation combined with the international high-end market access.
  • comments list

    [Henrytub  08月16日 04:57]  системный блок Сборка: Индивидуальность в каждой детали.
    [MichaelNig  08月16日 04:53]  Why Choose stout.lat Stablecoin First Mint DUSX manage LTV and access staking based value Connect and Earn Wallet dashboard for collateral APR and pending rewards DeFi Engine Stake LP lock boost or unlock veSTTX and earn stable APY Decentralized Tools Telegram Twitter Docs and PSM modules for ecosystem growth Join the new wave of stable finance at https://stout.lat
    [RobertRew  08月16日 04:52]  Бог судьба этому сайту
    [Haroldalips  08月16日 04:47]  Источник водкабет
    [Haroldalips  08月16日 04:47]  ссылка на сайт Зеркало vodka bet
    Total 1089/47069 Pages Frist Prev Prev10  1081   1082   1083   1084   1085   1086   1087   1088  1089  1090  Next10 Next Last

    I want to comment

    content*
    Your name
    Verify code* 
  • Go Top
Shijiazhuang Rainbowlabs pharmaceutical Technology Co. Ltd  Copyright